<?xml version="1.0" encoding="utf-8"?>
	<collection>
		
	
		<source>SourceData</source>
		
	
		<date>2019-04-19</date>
		
	
		<key>sourcedata.key</key>
		
	
		<document>
			
		
			<id>5239994 Figure_1-A</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 1-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. MS/MS analysis of peptides corresponding to amino acids 380-399 of STAT2. 293T cells expressing flag-tagged STAT2 were used.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="99"/>
					
				
					<text>flag</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_1-B</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 1-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_1-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B. Abundance of T387 phosphorylated STAT2 in 293T cells expressing flag-tagged STAT2.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="67"/>
					
				
					<text>flag</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_2-A</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 2-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. U6A cells expressing wild-type or T387A STAT2 were treated with IFN-β (100 IU/ml). Cells were harvested after 4 h and total RNAs were analyzed by real-time PCR. Values are the means ± SD from three independent experiments.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="67"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_2-B</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 2-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B. U6A cells expressing wild-type, T387A, or T387D STAT2 were treated with IFN-β (100 IU/ml). Cells were harvested after 4 h and total RNAs were analyzed by real-time PCR. Values are the means ± SD from three independent experiments.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="75"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_2-C-D</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 2-C-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C, D. U6A cells expressing wild-type or T387A STAT2 were treated with IFN-β for 0, 4, 8, or 24 h. Total RNAs were analyzed by using an Illumina HumanHT-12 v4 Expression BeadChip array. The average signal for each probe was used to determine expression levels. Genes with average signals below 25 and detection P values greater than 0.01 in the untreated or treated cells were excluded from the analysis. Inductions of less than 2-fold were not scored. The Venn diagram shows the numbers of genes induced by 1.2 fold or more in U6A cells expressing T387A STAT2, relative to untreated control cells. The numbers in the table are fold changes calculated from the ratios T387A STAT2 treated / untreated and wild-type STAT2 treated / untreated.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="70"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_3-A</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 3-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. HME cells expressing wild-type, T387A, or T387D STAT2 were seeded in 96-well plates at 8000 cells/well. The cells were exposed to vesicular stomatitis virus (VSV) for 2 h, with or without pre-treatment with IFN-β (100 IU/ml). After 20 h, the amounts of the VSV-M and STAT2 proteins were analyzed by the Western method.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:STAT2</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="51"/>
					
				
					<text>STAT2</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:STAT2</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="5" offset="271"/>
					
				
					<text>STAT2</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="3" offset="210"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_3-B</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 3-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B, C. HME cells expressing wild-type, T387A, or T387D STAT2 were seeded in 96-well plates at 8000 cells/well. On the second day, the cells were treated with IFN-β (10 IU/ml) for 2 h. The cells were then exposed to different multiplicities of infection of VSV for 2 h, followed by fresh media containing 10 IU/ml of IFN-β. The cells were analyzed by staining with crystal violet (B) after 48 h.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:violet</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="6" offset="373"/>
					
				
					<text>violet</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:STAT2</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="5" offset="54"/>
					
				
					<text>STAT2</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="3" offset="157"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
			
				<annotation id="4">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">4</infon>
					
				
					<infon key="sourcedata_article_annot_id">4</infon>
					
				
					<location length="3" offset="316"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_3-C</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 3-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B, C. HME cells expressing wild-type, T387A, or T387D STAT2 were seeded in 96-well plates at 8000 cells/well. On the second day, the cells were treated with IFN-β (10 IU/ml) for 2 h. The cells were then exposed to different multiplicities of infection of VSV for 2 h, followed by fresh media containing 10 IU/ml of IFN-β. The cells were analyzed by the MTT assay (C) after 48 h.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:STAT2</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="54"/>
					
				
					<text>STAT2</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="157"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="3" offset="316"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_3-D</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 3-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D. U6A cells expressing wild-type, T387A, or T387D STAT2 were placed into 96 well plates (2000 cells/well) and the cells were treated with IFN-β (1000 IU/ml) for 96 h. Cell survival was analyzed by the MTT assay. Each experiment was carried out two independent times, with results similar to the representative examples that are shown.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="139"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_4-A</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 4-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. An immuno-precipitation was performed using whole cell lysates from cells expressing Flag-tagged wild-type STAT2, and samples were analyzed by the Western method. The numbers in the chart are the proportions of T387 phosphorylated STAT2 in each cell type, calculated in comparison with 293T cells.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="88"/>
					
				
					<text>Flag</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_4-B</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 4-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B. HME cells expressing wild-type STAT2 were treated with IFN-β (100 IU/ml). Whole cell lysates harvested at the times indicated were analyzed by the Western method;</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="58"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_4-C</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 4-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C. HME cells expressing wild-type STAT2 were seeded in complete medium. On the second day, the cells were re-fed with medium lacking supplements. On the third day, the cells were treated with each supplement for 4 h, and total lysates were analyzed by the Western method. 1. EGF, 2. Insulin, 3. Hydrocortisone, 4. GA-1000, 5. BPE.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:EGF</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="275"/>
					
				
					<text>EGF</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_4-D</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 4-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D. HME cells were pretreated with hydrocortisone (0.04mg/ml and 0.4mg/ml) for 3 h and then treated with IFN-β (100 IU/ml). Cells were harvested after 4 h and total RNAs were analyzed by real-time PCR. Values are the means ± SD from three independent experiments.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:hydrocortisone</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="14" offset="34"/>
					
				
					<text>hydrocortisone</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="104"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_4-F</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 4-F</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-F</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>F. HCC827 and LnCAP cells expressing wild-type STAT2 were treated with CDK inhibitors (1 µM) for 4 h and whole-cell lysates were analyzed by the Western method. 1. Flavopiridol, 2. AT7519, 3. Dinaciclib.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_5-A</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 5-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. U6A cells expressing wild-type or T387A STAT2 were treated with IFN-β (100 IU/ml) for 30 min or were untreated. The cells were washed with PBS and the media was replaced with fresh media containing staurosporine (500 nM). Whole-cell lysates were harvested and analyzed by the Western method;</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="67"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_5-B</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 5-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B. U6A cells expressing wild-type or T387A STAT2 were treated with IFN-β (100 IU/ml) for 4 h or were untreated. Whole-cell lysates were used for immunoprecipitations of IRF9 and Flag-STAT2.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IRF9</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="170"/>
					
				
					<text>IRF9</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:Flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="4" offset="179"/>
					
				
					<text>Flag</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="3" offset="67"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_5-C</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 5-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C. U2A cells expressing wild-type or T387A STAT2 were treated with IFN-β (100 IU/ml) for 4 h or were untreated. Whole-cell lysates were used for immunoprecipitation of Flag-STAT2.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="169"/>
					
				
					<text>Flag</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="67"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_5-D</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 5-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D. U3A cells expressing wild-type or T387A STAT2 were treated with IFN-β (100 IU/ml) for 4 h or were untreated. Whole-cell lysates were used for immunoprecipitation of Flag-tagged STAT2.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:Flag</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="4" offset="169"/>
					
				
					<text>Flag</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="3" offset="67"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5239994 Figure_5-E</id>
			
		
			<infon key="sourcedata_document">2479</infon>
			
		
			<infon key="doi">10.15252/embj.201694834</infon>
			
		
			<infon key="pmc_id">5239994</infon>
			
		
			<infon key="figure">Figure 5-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>E. EMSAs using an ISRE probe. Extracts from U6A cells expressing wild-type or T387A STAT2 treated with IFN-β for 1 h were analyzed. The position of ISGF3 is labeled.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:IFN</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="3" offset="103"/>
					
				
					<text>IFN</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		

	</collection>
